跳至主要内容
临床试验/NCT05316454
NCT05316454已完成不适用

Effect of Self-Efficacy Support on Medication Adherence and Self-Efficacy Levels in Hypertension Patients: A Randomized Controlled Trial

Ataturk University1 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2021年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
63
试验地点
1
主要终点
Self-Efficacy - Efficacy Scale

研究概览

简要总结

Background:Health professionals are responsible for the education of hypertension patients.

Aim:The aim of this research is to see how self-efficacy support affects hypertension patients' medication adherence and self-efficacy levels.

Methods: This research is randomized controlled interventional research. The research is conducted inTurkey June-December2021.The research sample included 63hypertension patients who met the research's research requirements.According to the sequence of the arrival at the hospital, data were separated into groups with odd(intervention group)and double(control group)numbers.The necessary forms for both groups' pre-test data were filled out face-to-face. The intervention group received hands-on blood pressure measurement training with the "Hypertension Training Manual",including how to self-measure blood pressure.Over the course of the research, patients were asked to check their blood pressure twice a day at home and record the results.The patients in the intervention group were reminded of their blood pressure measurement three times a week by SMStechnique for three months to avoid forgetting it.Three months later, the same forms for the post-test data of both groups were filled out with an online survey method.The data were evaluated using the single-blind study.

详细描述

Background:Health professionals are responsible for the education of hypertension patients.

Aim:The aim of this research is to see how self-efficacy support affects hypertension patients' medication adherence and self-efficacy levels.

The Research's Population and Sample Hypertension patients who applied to the cardiology outpatient clinics at a Hospital in Turkey between June and December 2021 formed the target population of the research. The research sample included 63 hypertension patients over the age of 18 who met the research requirements and agreed to participate.

A priori power analysis was used to determine the sample size, and it was determined that each of the intervention and control groups needed at least 30 hypertension patients for the research's power to exceed 80% at the 95% confidence interval, 0.05 significance level, and medium effect size. Given the possibility of data loss owing to a variety of factors, it was decided to include 100 hypertension patients in the research sample. Because 12 patients wished to withdraw from the research and 25 patients did not complete the final applications, the research sample consisted of 63 hypertension patients, 31 in the intervention group and 32 in the control group.

Criteria for Research Inclusion All intervention and control groups were required to meet the inclusion criteria below.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
50 Years 至 72 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •All intervention and control groups were required to meet the inclusion criteria below.
  • •With a diagnosis of essential hypertension, follow up for at least 6 months,
  • •Using antihypertensive drugs,
  • •Not changing the antihypertensive medication in the last 1 month,
  • •Not having mental or communication problems,
  • •Being the age of 18 or older,
  • •Having at least primary education level,
  • •Not being a pregnant or nursing mother.

排除标准

  • •All intervention and control groups were required to meet the inclusion criteria below.
  • •With a diagnosis of essential hypertension, follow up for at least 6 months,
  • •Using antihypertensive drugs,
  • •Not changing the antihypertensive medication in the last 1 month,
  • •Not having mental or communication problems,
  • •Being the age of 18 or older,
  • •Having at least primary education level,
  • •Not being a pregnant or nursing mother.

研究组 & 干预措施

Experimental

Experimental

Patients with hypertension benefit from self-efficacy support in terms of medication adherence and self-efficacy.

干预措施: self-efficacy support (Behavioral)

Control

No Intervention

No change.

结局指标

主要结局

Self-Efficacy - Efficacy Scale

时间窗: 3months

The scale evaluates generic self-efficacy-efficacy perception and does not belong to any subjective category. The Self-Efficacy-Efficacy Scale is a 23-item, 5-point Likert-type scale with a minimum of 23 points and a maximum of 115 points.

Medication Adherence Self-Efficacy Scale in Hypertensive Patients

时间窗: 3months

The scale consists of 13 items and is in a four-point Likert type. The scale can be used to determine the lowest 13 and highest 52 points. The increase in the scale score shows that the individuals' compliance with the antihypertensive medication is above average.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bahar Ciftci

Principal Investigator

Ataturk University

研究点 (1)

Loading locations...

相似试验